|

FES Clinical Trials

1 actively recruiting trial

No change since March 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Università Vita-Salute San Raffaele1

Indications

  • Luminal A Breast Cancer1
  • Axillary Lymphadenopathy1
  • PET/MRI1
  • Lobular Breast Carcinoma1
  • Breast Cancer Female1

Other1 trial

18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.